Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Flying L Partners is a venture capital firm founded in 2016 by experienced professionals in the ophthalmic sector. The firm is headquartered in California and focuses exclusively on the ophthalmic market, investing in medical devices and pharmaceuticals. Since its inception, Flying L Partners has established itself as a key player in this niche, with a commitment to identifying and supporting innovative companies that advance ophthalmic technology and treatments.
The firm operates with a team of seasoned experts, led by Managing Partner Dr. William J. Link, Ph.D., who has over 30 years of experience in the ophthalmic venture capital space. Flying L Partners has successfully raised capital for various opportunities, actively engaging with portfolio companies to accelerate their growth. The firm has a strong track record of successful exits, with multiple companies acquired by major pharmaceutical and medical device conglomerates.
As of 2023, Flying L Partners has invested in over five companies that have been acquired, showcasing its ability to identify high-potential opportunities. The firm has also been recognized in the OC500 2024 list, highlighting its influence in the Orange County business community. Their approach combines deep industry knowledge with a hands-on engagement model, ensuring that portfolio companies receive the support they need to thrive.
Flying L Partners specializes in the ophthalmic sector, focusing on medical devices and pharmaceuticals. The firm invests in companies at various stages, from Series A through Series H and growth equity. Their check sizes typically start at $25 million, reflecting their commitment to significant investments that can drive substantial growth. The firm actively collaborates with its portfolio companies, leveraging its extensive industry knowledge and connections to enhance innovation and market impact.
The investment strategy of Flying L Partners is centered on identifying promising opportunities within the ophthalmic market. They seek companies that demonstrate potential for innovation and advancement in ophthalmic technology. The firm emphasizes the importance of active engagement with portfolio companies, working closely to foster growth and facilitate the development of groundbreaking treatments and devices.
Geographically, Flying L Partners focuses on the United States, although its portfolio companies may operate globally. This concentrated approach allows the firm to maintain a deep understanding of the market dynamics and trends within the ophthalmic sector, positioning them to make informed investment decisions.
Flying L Partners has built a notable portfolio of companies within the ophthalmic sector, showcasing its commitment to advancing medical technology. Key portfolio companies include:
In addition to these current investments, Flying L Partners has a strong track record of notable exits, including:
Dr. William J. Link, Ph.D. — Managing Partner. Dr. Link is a pioneering figure in ophthalmic venture capital with over 30 years of experience. He has led investments in numerous successful ophthalmic companies, including Glaukos and RxSight. Dr. Link is recognized for his contributions to the field and has served on various boards, including RxSight since November 2016.
Under Dr. Link's leadership, Flying L Partners has established a strong reputation in the ophthalmic investment community, with a focus on fostering innovation and growth in the sector. His extensive background includes founding and investing in approximately 30 ophthalmic companies, showcasing his deep expertise and commitment to advancing the field.
To pitch to Flying L Partners, founders should visit their website at flyinglpartners.com. The firm prefers detailed decks that outline the business model, market opportunity, and competitive landscape. While there are no formal application forms, a well-structured pitch deck is essential.
Response times may vary, but founders can expect to hear back within a few weeks after submission. Warm introductions are beneficial, as they can facilitate a more favorable review process.
In recent activity, Flying L Partners led a $25 million investment in the Series H round for RxSight, a company specializing in adjustable intraocular lens technology. This investment is part of RxSight's total Series H funding, which exceeded $46 million. The firm has been recognized for its successful track record, with multiple exits including Glaukos, which is now publicly traded on the NYSE.
Additionally, Flying L Partners has been named to the OC500 2024 list, highlighting Dr. William J. Link's influence in the Orange County business community. The firm continues to actively seek new investment opportunities within the ophthalmic sector, reinforcing its commitment to driving innovation and growth.
What are Flying L Partners' investment criteria?
Flying L Partners focuses on the ophthalmic sector, specifically targeting medical devices and pharmaceuticals. They invest in companies at various stages, from Series A to Series H, with check sizes typically starting at $25 million.
How can I apply or pitch to Flying L Partners?
Founders interested in pitching to Flying L Partners can visit their website at flyinglpartners.com for more information on the application process.
What makes Flying L Partners different from other venture capital firms?
The firm distinguishes itself through its exclusive focus on the ophthalmic sector and its active engagement with portfolio companies. Their deep industry expertise allows them to provide valuable insights and support to enhance innovation and growth.
What is the geographic scope of Flying L Partners' investments?
Flying L Partners primarily focuses on investments within the United States, although their portfolio companies may operate on a global scale.
What is Flying L Partners' post-investment involvement like?
The firm is known for its hands-on approach, actively collaborating with portfolio companies to drive growth and innovation. They leverage their extensive industry connections to support their companies in achieving their goals.
What is the fund size or total AUM of Flying L Partners?
While specific fund sizes and total AUM figures are not publicly disclosed, Flying L Partners has been active in raising capital for significant investments, indicating a strong financial backing for their initiatives.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.